Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children

Eric K France1, Jason Glanz, Stanley Xu

  • 1Department of Preventive Medicine, Kaiser Pemanente Colorado, Denver, CO 80231, USA. eric.k.france@kp.org

Pediatrics
|March 4, 2008
PubMed

Insights

The measles-mumps-rubella (MMR) vaccine may increase the risk of immune thrombocytopenia purpura (ITP) in children. This study found that 76% of ITP cases in toddlers were linked to the MMR vaccine, causing 1 case per 40,000 doses.

Area of Science:

  • Pediatric immunology
  • Vaccine safety research
  • Epidemiology

Background:

  • Previous small studies suggested a link between the measles-mumps-rubella (MMR) vaccine and immune thrombocytopenia purpura (ITP).
  • Further investigation was warranted to confirm this association and quantify the risk.

Purpose of the Study:

  • To evaluate the association between the MMR vaccine and the incidence of ITP in children.
  • To determine the risk of ITP following MMR vaccination in different age groups.

Main Methods:

  • A retrospective cohort study using the Vaccine Safety Datalink database.
  • Identified children aged 1-18 years who received the MMR vaccine.
  • Defined ITP cases based on platelet count (< or = 50,000/microL) with clinical bleeding and normal blood counts.
  • Calculated incidence rates and incident rate ratios (IRRs) for exposed and unexposed periods, focusing on ages 12-23 months.

Main Results:

  • Over 1 million MMR vaccine doses were administered to 1,036,689 children, with 259 confirmed ITP cases.
  • The incidence rate ratio for ITP was highest in children aged 12-15 months (IRR=7.10).
  • Boys aged 12-15 months had a significantly higher IRR (14.59) compared to girls (3.22).
  • Approximately 76% of ITP cases in 12-23 month olds were attributable to the MMR vaccine, estimating 1 case per 40,000 doses.

Conclusions:

  • The MMR vaccine administered in the second year of life is associated with an increased risk of developing immune thrombocytopenia purpura.
  • The findings highlight a specific risk period for ITP following MMR vaccination, particularly in young children.
Abstract

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccinations01:51

Vaccinations

Overview
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...